CST3 and diabetic foot: Cystatin C not only has a stronger ability than serum creatinine to predict mortality and the development of end-stage renal disease in diabetic patients (46, 47) but also has a strong correlation with the poor healing of diabetic foot ulcers (48) and the risk of cardiovascular disease, which seems to be associated with promoting atherosclerosis through multiple pathways (49).